4.6 Article

Neuroimaging mechanisms of high-frequency repetitive transcranial magnetic stimulation for treatment of amnestic mild cognitive impairment: a double-blind randomized sham-controlled trial

期刊

NEURAL REGENERATION RESEARCH
卷 16, 期 4, 页码 707-713

出版社

WOLTERS KLUWER MEDKNOW PUBLICATIONS
DOI: 10.4103/1673-5374.295345

关键词

Alzheimer's disease; clinical trial; cognitive function; cognitive impairment; functional magnetic resonance imaging; neurological function; repetitive transcranial magnetic stimulation

资金

  1. National Natural Science Foundation of China [81874032]
  2. Science and Technology Planning Project of Shenzhen of China [JCYJ20160427191726109]
  3. Science and Technology Planning Project of Guangdong Province of China [2016A020215202]
  4. Shenzhen Health and Family Planning System Research Project of China [SZXJ2017069]

向作者/读者索取更多资源

The study demonstrates that high-frequency rTMS can effectively improve cognitive function and alter brain activity in cognitive-related areas of patients with amnestic mild cognitive impairment. Assessment scores showed a significant increase in the rTMS group compared to baseline, with sustained efficacy observed at the end of treatment and one month later.
Individuals with amnestic mild cognitive impairment (aMCI) have a high risk of developing Alzheimer's disease. Although repetitive transcranial magnetic stimulation (rTMS) is considered a potentially effective treatment for cognitive impairment in patients with aMCI, the neuroimaging mechanisms are poorly understood. Therefore, we performed a double-blind randomized sham-controlled trial in which rTMS was applied to the left dorsolateral prefrontal cortex of aMCI patients recruited from a community near the Third Hospital Affiliated to Sun Yat-sen University, China. Twenty-four patients with aMCI were randomly assigned to receive true rTMS (treatment group, n = 12, 6 men and 6 women; age 65.08 +/- 4.89 years) or sham stimulation (sham group, n = 12, 5 men and 7 women; age 64.67 +/- 4.77 years). rTMS parameters included a stimulation frequency of 10 Hz, stimulation duration of 2 seconds, stimulation interval of 8 seconds, 20 repetitions at 80% of the motor threshold, and 400 pulses per session. rTMS/sham stimulation was performed five times per week over a period of 4 consecutive weeks. Our results showed that compared with baseline, Montreal Cognitive Assessment scores were significantly increased and the value of the amplitude of low-frequency fluctuation (ALFF) was significantly increased at the end of treatment and 1 month after treatment. Compared with the sham group, the ALFF values in the right inferior frontal gyrus, triangular part of the inferior frontal gyrus, right precuneus, left angular gyrus, and right supramarginal gyrus were significantly increased, and the ALFF values in the right superior frontal gyrus were significantly decreased in the treatment group. These findings suggest that high-frequency rTMS can effectively improve cognitive function in aMCI patients and alter spontaneous brain activity in cognitive-related brain areas. This study was approved by the Ethics Committee of Shenzhen Baoan Hospital of Southern Medical University, China (approval No. BYL20190901) on September 3, 2019, and registered in the Chinese Clinical Trials Registry (registration No. ChiCTR1900028180) on December 14, 2019.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据